Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Chris Vercammen, Xavier Warling et al.|The Lancet|2019

Cited by 609